sun pharma semaglutide India's wins South Africa approval to launch generic Ozempic Semaglutide Goes Generic; Sun Pharma,

Addressing Risks When Stopping or Pausing GLP-1s Stopping or pausing GLP-1 therapy can lead to changes in blood sugar and potential weight regaining

Even though minimizing food noise is key to weight loss, it could ultimately be unsafe: Mild fatigue is typically not dangerous, but persistent or overwhelming tiredness could indicate underlying issues like low blood sugar or excessive calorie restriction, he tells us

Once generic semaglutide becomes available, patients can expect significant cost savings

Despite its popularity, a 2025 review found only three published human studies on the peptide BPC-157

Moreover, RT-qPCR on isolated DTCs showed that tig-2 was upregulated in the DTC of glp-1 mutants, as the RNA-Seq data suggested (Figs